Preliminary experiments show conolidine may well inhibit unique ion channels, cutting down neuronal excitability and restricting agony alerts. This system is particularly relevant in neuropathic discomfort, in which abnormal signaling triggers persistent distress. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to soreness https://jonathanb162vme8.p2blogs.com/profile